Pulmonary arterial hypertension
MONDO:0015924Pulmonary arterial hypertension (PAH) is a group of diseases characterized by mean pulmonary artery pressure >20 mmHg and elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, have overt features of venous/capillary involvement (pulmonary veno-occlusive disease, PVOD/pulmonary capillary hemangiomatosis, PCH), induced by drug or toxin (drug-or toxin-induced PAH), or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease).
Also known as: PAH, pulmonary arterial hypertension, PAH with overt features of venous/capillaries involvement, PVOD/PCH, PPH, idiopathic pulmonary hypertension
323 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a Protein-Rich diet and strength training boost heart recovery?
Disease control CompletedThis study explores whether combining a high-protein Mediterranean diet with resistance exercise can help people with heart disease build muscle and lower their risk of future heart problems. The trial enrolls adults who have completed cardiac rehab and may have low muscle mass w…
Phase: NA • Sponsor: Liverpool John Moores University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Walking your way to better health: smartphone program shows promise for heart and diabetes patients
Disease control CompletedThis study tests whether a three-month smartphone-supported walking program can improve daily step counts, psychological well-being, and body composition in adults with cardiovascular disease or type 2 diabetes. Participants use the Walk15 app to set personalized step goals and t…
Phase: NA • Sponsor: Klaipėda University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New coaching model boosts cardiac rehab use in seniors
Disease control CompletedThis study tested a coaching program called MACRO-I for adults aged 70 and older who had a heart event. The program used coaches to guide patients through starting cardiac rehab, either at a center, at home, or a mix of both. 416 participants were split into the coaching group or…
Phase: NA • Sponsor: Daniel Forman, MD • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New PAH pill aims to delay worsening in large trial
Disease control CompletedThis study tested a new oral drug called ralinepag in 687 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work harder. Participants took ralinepag or a placebo on top of their usual PAH medications. The main goal was to see if rali…
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for japanese PAH patients: experimental drug shows promise in phase 3 trial
Disease control CompletedThis study tested a drug called sotatercept (MK-7962) in 46 Japanese adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work harder. Participants took the drug alongside their usual treatments. The main goals were to see if it improve…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Can bosentan reverse lung artery thickening? small study investigates
Disease control CompletedThis study looked at whether bosentan (Tracleer) can reduce the thickness of lung artery walls in people with a type of high blood pressure in the lungs (pulmonary arterial hypertension, or PAH). Eleven adults with PAH took bosentan for 6 months. Researchers measured artery wall …
Phase: PHASE4 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for severe lung disease: drug delays death and hospitalization
Disease control CompletedThis study tested a drug called sotatercept in 173 people with severe pulmonary arterial hypertension (PAH), a serious lung condition that makes the heart work too hard. Participants received either the drug or a placebo on top of their usual treatments. The goal was to see if th…
Phase: PHASE3 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New inhaled drug shows promise for rare lung disease
Disease control CompletedThis study tested an inhaled medication called seralutinib in 390 adults with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe and limits physical activity. The goal was to see if the drug improves how far patients can walk in six minu…
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for kids with rare lung condition: macitentan shows promise in small study
Disease control CompletedThis study tested the drug macitentan in 7 Japanese children aged 3 months to 15 years with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs strains the heart. The goal was to see if the drug improves blood flow and heart function after 24…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Old drug, new hope for right heart failure?
Disease control CompletedThis study tested the drug spironolactone in 15 adults with chronic right-sided heart failure. The goal was to see if it is safe and can improve heart function and reduce stress on the heart. Participants took either the drug or a placebo to compare effects.
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New daily pill could rival insulin for diabetes and heart risk
Disease control CompletedThis study tested a once-daily pill called orforglipron against insulin glargine in nearly 2,750 adults with type 2 diabetes, obesity or overweight, and increased cardiovascular risk. The main goal was to see if orforglipron could reduce major heart events like heart attacks or s…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Can a new drug help PAH patients breathe easier during exercise?
Disease control CompletedThis study tested whether the drug sotatercept, given for 36 weeks, improves how the heart and lungs work during exercise in people with pulmonary arterial hypertension (PAH). Thirty adults with PAH received injections of sotatercept. Researchers measured heart pressure, blood fl…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New imaging reveals how CS1 drug may reshape lung arteries in PAH patients
Disease control CompletedThis study looked at how the drug CS1 changes the structure of small lung arteries in people with pulmonary arterial hypertension (PAH). Seven patients already taking CS1 in an expanded access program had special CT scans at the start and after 12 months. The goal was to see if C…
Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New inhaled drug shows promise for rare lung condition
Disease control CompletedThis phase 2b trial tested an inhaled powder form of treprostinil palmitil in 102 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe. The study compared the drug to a placebo to see if it could lower lung…
Phase: PHASE2 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for kids with rare lung disease: macitentan trial shows promise
Disease control CompletedThis study tested the drug macitentan in 165 children with pulmonary arterial hypertension (PAH), a serious lung condition. The children were randomly assigned to receive macitentan or standard care. The main goal was to see how the drug behaves in the body and whether it is safe…
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Two drugs better than one for kids with high blood pressure in lungs?
Disease control CompletedThis completed phase 3 trial tested whether giving children with pulmonary hypertension two drugs (sildenafil and bosentan) from the start works better than just one drug (sildenafil alone). The study enrolled 28 children who had not yet received long-term treatment. Researchers …
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Heart drug showdown: which protects the right ventricle better after valve surgery?
Disease control CompletedThis study tested two drugs, levosimendan and dobutamine, in 52 adults undergoing heart valve replacement. The goal was to see which one better preserves right ventricular function after surgery. Patients were randomly assigned to receive one of the drugs, and their heart functio…
Sponsor: Helwan University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Deep clean teeth to tame heart disease and diabetes?
Disease control CompletedThis study tested whether intensive dental cleaning and oral hygiene advice can improve gum health and also affect markers of heart disease and type 2 diabetes. About 200 adults with gum disease and either heart disease or diabetes (or prediabetes) took part. Researchers measured…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Blood filtering shows promise for high lipoprotein(a) in dialysis patients
Disease control CompletedThis small completed study looked at a blood filtering procedure called double-filtration plasmapheresis (DFPP) in 5 kidney dialysis patients with very high levels of lipoprotein(a), a fatty substance linked to heart disease and blood clots. The goal was to see if DFPP could lowe…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a common diabetes pill help people with rare lung disease breathe easier?
Disease control CompletedThis study tested the drug dapagliflozin (used for diabetes and heart failure) in 52 adults with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension. The goal was to see if it improves exercise capacity and heart function. Participants took the …
Phase: PHASE2 • Sponsor: Mads Ersbøll • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
HIV heart risk targeted: new drug shows promise in reducing arterial inflammation
Disease control CompletedThis study tested whether a drug called alirocumab, which lowers cholesterol, can reduce heart disease risk in people with HIV. The trial involved 118 adults aged 40 and older with well-controlled HIV and high heart disease risk. Participants received either alirocumab or a place…
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Two cholesterol drugs better than one? new study investigates
Disease control CompletedThis completed trial looked at whether taking two cholesterol-lowering drugs (rosuvastatin and ezetimibe) is more effective and safer than taking just one (rosuvastatin) for people with heart disease. 66 adults with high cholesterol were randomly assigned to one of the two treatm…
Phase: PHASE2, PHASE3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
One pill to rule them all? new combo therapy for PAH shows promise
Disease control CompletedThis study tested whether a single pill containing two drugs (macitentan and tadalafil) works better than taking either drug alone for people with pulmonary arterial hypertension (PAH), a serious lung condition. 187 adults with PAH took either the combination pill or one of the s…
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New dosing strategy for PAH drug under study
Disease control CompletedThis study looked at two ways of giving the drug sotatercept to people with pulmonary arterial hypertension (PAH), a condition where lung blood vessels narrow, making it hard to breathe. Researchers compared a standard weight-based dose to a simpler weight-banded dose to see how …
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Inhaled treprostinil shows promise for exercise capacity in PAH-ILD patients
Disease control CompletedThis study looked at how an inhaled drug called treprostinil helps patients with pulmonary hypertension caused by interstitial lung disease. Researchers measured heart function and breathing efficiency during exercise after 3 months of treatment. The goal was to understand how th…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a natural hormone help hearts in pulmonary hypertension?
Disease control CompletedThis study tested whether DHEA, a natural hormone, can improve heart function in people with pulmonary arterial hypertension (high blood pressure in the lungs). 26 adults took DHEA or a placebo for 18 weeks, then switched. The main goal was to see changes in heart strain measured…
Phase: PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill could slow worsening of rare lung disease
Disease control CompletedThis large Phase 3 study tested whether selexipag, a daily pill, can delay serious complications or death in people with pulmonary arterial hypertension (PAH), a rare condition of high blood pressure in the lungs. Over 1,100 adults with PAH received either selexipag or a placebo.…
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood pressure drug riociguat tested for Long-Term use in rare lung condition
Disease control CompletedThis study looked at the long-term safety of the drug riociguat (Adempas) in adults with pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. It included 18 people who had already taken riociguat in earlier Bayer studies. The main goal was to track s…
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New procedure shows promise for treating pulmonary hypertension
Disease control CompletedThis study tested a procedure called pulmonary artery denervation (PADN) for people with pulmonary arterial hypertension (PAH), a condition where blood pressure in the lungs is dangerously high. 128 adults received either the real procedure or a sham (fake) procedure. The goal wa…
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug shows promise for rare lung condition in early trial
Disease control CompletedThis study tested a new drug called ACT-293987 (NS-304) in 43 adults with pulmonary arterial hypertension (PAH), a condition where high blood pressure damages the lungs. The trial had two parts: first, a single dose to check how it affects blood flow, then 21 weeks where some peo…
Phase: PHASE2 • Sponsor: Actelion • Aim: Disease control
Last updated Jun 26, 2026 15:53 UTC
-
Heart scans could spare patients from invasive catheter procedures
Diagnosis CompletedThis study compares cardiac MRI to the standard right heart catheterization for monitoring people with pulmonary arterial hypertension (PAH), a condition that strains the heart. Researchers want to see if the non-invasive MRI can reliably detect when a patient's condition is wors…
Phase: NA • Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Eye scans may reveal hidden heart risks
Diagnosis CompletedThis study looked at whether a special eye scan (SS-OCTA) can detect signs of cardiovascular disease. Researchers compared retinal blood vessel changes to results from a standard carotid ultrasound in 42 adults. The goal was to see if the eye scan could predict the presence or se…
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
New MRI scan could replace risky heart catheterization for lung pressure diagnosis
Diagnosis CompletedThis study tested whether a special MRI technique called 4D flow can accurately measure blood pressure in the lungs of people with pulmonary hypertension. 28 patients had both the MRI and the standard invasive catheterization to compare results. If the MRI proves reliable, it cou…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Two or three workouts a week? study finds best exercise dose for seniors at risk
Prevention CompletedThis study looked at how often older adults with heart disease risk factors should exercise to improve fitness and blood pressure. Twenty-two participants did combined training either twice or three times a week for 12 weeks. The goal was to see which frequency worked better for …
Phase: NA • Sponsor: Universidade Federal de Santa Catarina • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Phone-based peer program aims to slash heart risk in low-income groups
Prevention CompletedThis study tested an 8-week digital lifestyle program called MYCardio-PEER for low-income adults at risk of heart disease. Participants received weekly videos and infographics on healthy eating and exercise, plus group chats with peer leaders. The goal was to see if the program i…
Phase: NA • Sponsor: Monash University Malaysia • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
Heart-Healthy women: exercise and brain games may ward off memory loss
Prevention CompletedThis study looked at whether a home-based physical activity program and computer-based cognitive training could help prevent memory loss in older women with heart disease. 253 women aged 65 and older participated. The goal was to see if these lifestyle changes could improve memor…
Phase: NA • Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Digital nudges boost flu vaccine uptake in High-Risk adults
Prevention CompletedThis completed study tested whether sending behavioral nudges through Denmark's official electronic letter system could increase flu vaccination among adults aged 18-64 with chronic diseases. Over 300,000 participants were randomly assigned to receive different types of letters o…
Phase: NA • Sponsor: Tor Biering-Sørensen • Aim: Prevention
Last updated Jun 26, 2026 15:51 UTC
-
New drug shows promise for easier breathing during exercise in PAH patients
Symptom relief CompletedThis study tested a single dose of an investigational drug called RT234 in 42 adults with pulmonary arterial hypertension (PAH), a condition that makes it hard to exercise due to high blood pressure in the lungs. The main goals were to see if the drug is safe and if it improves e…
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Saliva test reveals best pain relief for Open-Heart patients
Symptom relief CompletedThis study looked at two methods to reduce pain after heart surgery through a cut in the chest bone. 120 adults received either a nerve block near the breastbone, pain medicine injected into the wound, or standard painkillers. Researchers measured pain levels using a saliva test …
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Couples therapy for heart patients? new program aims to heal hearts together
Symptom relief CompletedThis completed trial tested an 8-week program called Healing Hearts Together (HHT) for couples where one partner has heart disease. 474 couples attended weekly group sessions focused on communication, emotional support, and heart health. The goal was to see if the program improve…
Phase: NA • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Prayer and relaxation calm heart surgery patients, study finds
Symptom relief CompletedThis study tested whether a 20-minute session of nurse-led spiritual care, including prayer and relaxation techniques, could help heart surgery patients feel less anxious and have more stable blood pressure and heart rate before their operation. 248 adults in Indonesia took part.…
Phase: NA • Sponsor: Lincoln University College Malaysia • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New inhaled drug shows promise for easing lung pressure in rare Heart-Lung condition
Symptom relief CompletedThis study tested an inhaled medication called RT234 in 14 adults with pulmonary arterial hypertension (PAH), a condition where blood pressure in the lungs is dangerously high. The goal was to see if the drug could quickly lower lung blood pressure during a heart catheterization …
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Yoga boosts heart recovery in seniors, pilot finds
Symptom relief CompletedThis study tested whether a 3-month yoga program could improve physical and mental health in adults over 65 who had recently finished cardiac rehab. Participants attended yoga twice a week. Researchers measured balance, muscle strength, anxiety, and mood. The goal was to see if y…
Phase: NA • Sponsor: Geunyeong Cha • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Oxygen on the go: do patients really need it during exercise?
Symptom relief CompletedThis study tested whether people with pulmonary vascular disease (problems with blood vessels in the lungs) can walk the same distance in 6 minutes without extra oxygen as they can with it. 40 adults who had low oxygen levels during exercise did two walk tests—one breathing norma…
Phase: NA • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Heart patients find relief with online therapy program
Symptom relief CompletedThis study tested a 9-week internet-based cognitive behavioral therapy (CBT) program designed to reduce stress, anxiety, and depression in people with stable heart disease. 215 adults with heart disease and elevated stress or mood symptoms took part. The program was personalized …
Phase: NA • Sponsor: University Hospital, Linkoeping • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Could slow breathing help PAH patients breathe easier?
Symptom relief CompletedThis study tested whether slow-paced breathing at home can help people with pulmonary arterial hypertension (PAH) manage symptoms like shortness of breath, fatigue, and poor sleep. Forty-two adults with stable PAH took part, with one group adding slow breathing exercises to their…
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Virtual reality boosts mood in heart rehab, study finds
Symptom relief CompletedThis study tested whether adding virtual reality (VR) driving simulations to standard cardiac rehabilitation helps heart surgery patients feel less anxious and depressed. Sixty adults recovering from heart surgery took part. The results suggest VR can improve emotional well-being…
Phase: NA • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a diabetes drug help PAH patients walk farther?
Symptom relief CompletedThis study tested whether metformin, a common diabetes drug, along with a text-message activity program, could help people with pulmonary artery hypertension (PAH) walk farther and feel better day-to-day. 73 adults with PAH took part. The goal was to see if these interventions im…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can breathing training help people with lung blood pressure?
Symptom relief CompletedThis study tested whether 8 weeks of inspiratory muscle training (breathing exercises using a device) could improve exercise capacity in 32 people with pulmonary hypertension. Participants were randomly assigned to either active training or a placebo version. The goal was to see …
Phase: NA • Sponsor: Federal University of São Paulo • Aim: Symptom relief
Last updated Jun 26, 2026 17:58 UTC
-
Family secrets? study maps how relatives talk about genetic health risks
Knowledge-focused CompletedThis study explored how family members share health information about genetic diseases like sickle cell, diabetes, and cancer. Over 1,000 adults completed surveys or interviews about their family health history and support. The goal was to understand social and relational factors…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Small study aims to unlock secrets of rare lung disease
Knowledge-focused CompletedThis completed Phase 1 study looked at 27 people with and without pulmonary hypertension to learn more about how blood vessel problems contribute to the disease. Researchers used heart catheterization, imaging, and blood tests to find biomarkers and understand disease mechanisms.…
Phase: PHASE1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New MRI technique could make heart procedures safer and faster
Knowledge-focused CompletedThis study tests whether special low-energy MRI settings can make it safe to use guidewires during heart catheterization. Guidewires help position catheters but can heat up in standard MRI. Researchers will enroll 22 adults who need a right heart catheterization to see if this ap…
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New 3D ultrasound may spot High-Risk heart patients without needles
Knowledge-focused CompletedThis study tested whether a new 3D ultrasound technique can predict how well patients with pulmonary hypertension will do. Researchers followed 150 patients for six months, collecting heart images and tracking deaths and hospitalizations. The goal was to see if this non-invasive …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple gas protect organs during surgery?
Knowledge-focused CompletedThis pilot study tested whether giving inhaled nitric oxide gas during laparoscopic surgery could protect blood vessels and organs in 40 adults with heart disease. Half received the gas through their breathing tube during surgery, and half received standard care. Researchers meas…
Phase: NA • Sponsor: Alexander Averyanov • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Skin patch could replace needle sticks during exercise tests
Knowledge-focused CompletedThis study tested a skin sensor that measures carbon dioxide (CO2) levels continuously during exercise, comparing it to standard blood tests. Researchers included 140 healthy volunteers and people with lung or heart conditions. The goal was to see if the sensor could accurately t…
Phase: NA • Sponsor: Centre Hospitalier Metropole Savoie • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Can your genes predict blood thinner success? new study targets caribbean hispanics
Knowledge-focused CompletedThis study looked at 150 Caribbean Hispanic adults with heart disease or stroke risk who take the blood thinner clopidogrel. Researchers wanted to see if certain gene variants affect how well the drug works. The goal is to understand why some people get less benefit and to pave t…
Phase: EARLY_PHASE1 • Sponsor: University of Puerto Rico • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Many heart patients skip their meds, study finds
Knowledge-focused CompletedThis study checked how well over 5,000 heart patients follow their prescribed medicine routine. Researchers asked patients about their medication habits and any side effects. The goal was to understand how many patients do not take their medicines as directed.
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New MRI scan could replace invasive heart test for lung pressure patients
Knowledge-focused CompletedThis study looked at whether a special MRI scan (4D Flow) can accurately measure blood flow to the lungs in people with both congenital heart disease and pulmonary hypertension. The standard test for this is a heart catheterization, which is invasive and uncomfortable. The study …
Phase: NA • Sponsor: Centre Chirurgical Marie Lannelongue • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New MRI technique could reveal hidden lung changes in PAH patients
Knowledge-focused CompletedThis study tested a special MRI that uses inhaled xenon gas to take detailed pictures of lung function in people with pulmonary arterial hypertension (PAH). Ten adults with PAH had four scans over 18 weeks to see how their lungs processed the gas. The goal was to find new ways to…
Sponsor: University of Kansas Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Can a doctor's referral to an exercise coach get people moving?
Knowledge-focused CompletedThis study tested a program where doctors refer inactive people with chronic diseases (like diabetes, heart disease, or obesity) to an exercise professional for personalized counseling. The goal was to see if this referral scheme helps people become more active compared to just g…
Phase: NA • Sponsor: University of Erlangen-Nürnberg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New turkish tool aims to spot depression in heart patients
Knowledge-focused CompletedThis study checked whether the Turkish version of the Cardiac Depression Scale (CDS) works well for people with heart disease. Researchers tested 360 Turkish adults with various heart conditions to see if the scale accurately measures depression. The goal is to give doctors a rel…
Sponsor: Kırıkkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Heart and mind: new study explores the hidden links between cardiovascular disease and mental illness
Knowledge-focused CompletedThis completed study looked at 400 people with both heart disease and a mental health condition (like depression or anxiety). Researchers used questionnaires, blood tests, and imaging to find shared risk factors and biological markers. The goal was to better understand how these …
Sponsor: Ningbo No. 1 Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
MRI scans could replace invasive heart tests for lung disease patients
Knowledge-focused CompletedThis study looked at whether cardiac MRI can accurately measure right heart function in 112 people with pulmonary arterial hypertension. Researchers compared MRI results with data from invasive heart catheterization. The goal was to see if MRI could be used to monitor disease and…
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Immune clues in rare lung disease explored
Knowledge-focused CompletedThis completed study looked at how the immune system might affect the outlook for people with pulmonary arterial hypertension (PAH). Researchers took blood and skin samples from 629 participants with different types of PAH to search for specific antibodies. The goal was to better…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Fitbit for the heart: tiny tracker may speed recovery after surgery
Knowledge-focused CompletedThis study looked at whether wearing an activity monitor (like a Fitbit) after heart surgery helps patients get moving sooner and return to their normal activity levels faster. Researchers tracked motivation, length of hospital stay, and readmission rates in 12 adults who had car…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Talking less meds: training helps doctors cut pills for seniors
Knowledge-focused CompletedThis study tested whether special communication training for pharmacists and general practitioners helps them involve older patients in decisions to stop or lower medications for heart disease and diabetes. Researchers enrolled 310 patients aged 75 and older who were taking certa…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Motivational letter may boost heart rehab Follow-Up attendance
Knowledge-focused CompletedThis study tested whether a theory-based motivational letter mailed six months in advance could increase attendance at a one-year post-cardiac rehabilitation check-up. Researchers compared 102 adults who received the letter to those who got usual care. The goal was to see if a si…
Phase: NA • Sponsor: University of Calgary • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Diabetes drug semaglutide put to the test: can it reveal secrets of the adrenal gland?
Knowledge-focused CompletedThis completed study gave 22 healthy men a single dose of semaglutide (Rybelsus) or a placebo pill to see how it affects cortisol and other stress hormones. The goal was not to treat any disease, but to learn more about how GLP-1 drugs interact with the body's stress system. Part…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Researchers dive into why scleroderma and lung hypertension weaken the heart
Knowledge-focused CompletedThis study looked at 43 adults with scleroderma or unexplained pulmonary arterial hypertension (PAH) to understand why the right side of the heart weakens. Researchers collected blood and tissue samples during routine procedures and measured heart function over 6 months. The goal…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Tiny study asks: does aspirin work in patients with low platelets?
Knowledge-focused CompletedThis study looked at how well a daily low-dose aspirin works in people who have both immune thrombocytopenia (low platelets) and heart disease. Only 4 adults took part. Researchers measured platelet function after aspirin to see if the standard dose is enough to prevent blood clo…
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Did a simple phone call keep chronic patients out of the hospital?
Knowledge-focused CompletedThis study tested whether a systematic phone call from a medical student, supervised by a general practitioner, could reduce hospitalizations in patients with chronic heart or mental health conditions during the COVID-19 lockdown in France. Over 22,000 patients aged 70 and older …
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Which risk score best predicts heart surgery survival?
Knowledge-focused CompletedThis study looked at 320 adults who had heart surgery to see how well two different risk scores (EuroSCORE-II and POSPOM) predict the chance of dying in the hospital. Researchers calculated each patient's scores before surgery and compared them to what actually happened. The goal…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Heart patients enjoy orienteering as much as walking in rehab study
Knowledge-focused CompletedThis study looked at whether orienteering (a navigation-based walk) is as good as regular walking for heart rehab. 40 people with stable heart disease took part. Researchers measured heart rate and enjoyment during both activities. The goal was to see if orienteering could be a f…
Sponsor: Fondation Ildys • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New ultrasound score may sharpen risk prediction for PAH patients
Knowledge-focused CompletedThis completed study looked at whether a new ultrasound score called VExUS can help doctors better assess risk in people with pulmonary arterial hypertension (PAH). Researchers measured VExUS in 86 adults and compared it to standard tests like heart catheterization and blood mark…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New breathing monitor could help doctors spot lung trouble faster
Knowledge-focused CompletedThis study tested whether a device called MYOTRACE, which measures how hard a person's breathing muscles are working, can help doctors assess patients with respiratory diseases. 56 adults with conditions like COPD or asthma were included. The goal was to see if the device's readi…
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New tool aims to better measure breathlessness in lung patients
Knowledge-focused CompletedThis study tested a new self-administered questionnaire called DYSLIM to measure shortness of breath and its impact on daily life in people with chronic respiratory diseases like COPD, cystic fibrosis, and pulmonary hypertension. Researchers enrolled 199 participants to check if …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Can air purifiers help heart patients? small study tests new approach
Knowledge-focused CompletedThis study tested an indoor air pollution intervention called AIRWISE in 20 adults aged 55 and older with heart disease. Participants received personal air cleaners, a color-changing air quality monitor, and educational materials. The goal was to see if they would use these tools…
Phase: NA • Sponsor: University of Montana • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Real-World data mimics heart trial for diabetes drugs
Knowledge-focused CompletedThis completed study tested whether healthcare claims data can predict the results of a major heart trial (SURPASS-CVOT) comparing two diabetes drugs, tirzepatide and dulaglutide. Researchers analyzed records from over 44,000 people with type 2 diabetes and heart disease to see i…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Can a heart drug spray help lung blood vessels?
Knowledge-focused CompletedThis study looked at whether breathing in nitroglycerin (a medicine that opens blood vessels) is safe and effective for people with pulmonary arterial hypertension (PAH), a condition where lung blood vessels narrow. Twenty adults with PAH took part. The goal was to see if the spr…
Phase: NA • Sponsor: Mansoura University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Small study probes Carnitine's role in rare lung disease
Knowledge-focused CompletedThis early-stage study looked at whether people with pulmonary arterial hypertension (PAH) have low carnitine levels and if taking carnitine supplements could help. Ten adults with PAH kept food diaries and had blood tests to measure carnitine. The goal was to gather information …
Phase: PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Inhaled ED drug tested for safety in healthy people
Knowledge-focused CompletedThis early-phase trial tested the safety and how the body processes an inhaled form of vardenafil (RT234) in 31 healthy adults. Participants received single and multiple doses of the drug via an inhaler or as a pill. The study is complete and focused on side effects and drug leve…
Phase: PHASE1 • Sponsor: Respira Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Drug combo for lung disease gets safety check in healthy volunteers
Knowledge-focused CompletedThis completed Phase 1 study looked at how two drugs, BIA 5-1058 and furosemide, affect each other when taken together. 44 healthy adults received each drug alone and then together, under fasting conditions. The goal was to measure drug levels and safety, not to treat any disease…
Phase: PHASE1 • Sponsor: Bial - Portela C S.A. • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:08 UTC
-
Pollution may worsen pregnancy dangers for heart patients
Knowledge-focused CompletedThis completed study looked at 1,200 pregnant women with pulmonary hypertension (high blood pressure in the lungs) to see if long-term exposure to air pollution raises the risk of serious pregnancy complications like heart failure or death. Researchers analyzed medical records an…
Sponsor: Wei Huang • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:16 UTC
-
Can asking patients about their needs reduce hospital visits?
Knowledge-focused CompletedThis study looked at two ways to assign care coordinators to older adults (65+) with heart disease or risk factors. One method used patients' own reports of difficulty coordinating care, while the other used usual triggers like hospital discharge. The goal was to see which approa…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:18 UTC